Skip to main content

Table 1 Socio-demographic and substance use characteristics of study participants

From: Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV

Characteristic

Total sample (n = 13)

Demographics

 Age, median [IQR]

46 [38, 52.5]

 Race and ethnicity, n (%)

  Black

5 (39)

  White

5 (39)

  Mixed

3 (23)

  Hispanic

7 (54)

 Employed, n (%)

2 (15)

 Income < $10,000, n (%)

7 (54)

 Unstably housed, n (%)

5 (42)

HIV-related variables

 Years living with HIV infection, median [IQR]

14.3 [9.3, 18.5]

 Years on ART, median [IQR]

10 [5, 19]

 Poor ART adherence (CASE ≤ 10), n (%)

9 (69)

Substance use

 Stage of readiness to change (MA use cessation), n (%)

  Precontemplation

1 (7)

  Contemplation

7 (54)

  Action

5 (39)

 Possible MA use disorder (DAST≥ 6), n (%)

6 (46)

  1. IQR interquartile range, ART antiretroviral therapy, MA methamphetamine, CASE Center for Adherence Support Evaluation, DAST Drug Abuse Screening Test